Tofacitinib Reduce la Inflamación Espinal en Cuerpos Vertebrales y Elementos Posterolaterales en la Espondilitis Anquilosante: Resultados de un ensayo de fase 2
Rheumatol Ther. 2023;10(4):1001–1020 doi 10.1007/s40744-023-00564-y
Tofacitinib treatment is associated with a significant improvement in CANDEN MRI scores of spinal inflammation in axSpA patients. This study by Østergaard, et al. also validates the CANDEN MRI scoring system as an approach for measuring axSpA-associated inflammatory lesions.